Tsai, H-T <br/><br/>
Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study.  [electronic resource] 

 -  Breast cancer research and treatment  Feb 2014 
 - 163-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-014-2836-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Cohort Studies<br/>Female<br/>Heart Diseases--chemically induced<br/>Humans<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Risk Factors<br/>SEER Program<br/>Trastuzumab